Compare GHRS & STRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GHRS | STRA |
|---|---|---|
| Founded | 2018 | 2017 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 2021 | 1996 |
| Metric | GHRS | STRA |
|---|---|---|
| Price | $28.23 | $81.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | $41.38 | ★ $87.00 |
| AVG Volume (30 Days) | ★ 252.2K | 218.1K |
| Earning Date | 05-01-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.04% |
| EPS Growth | N/A | ★ 15.85 |
| EPS | N/A | ★ 3.19 |
| Revenue | N/A | ★ $997,137,000.00 |
| Revenue This Year | N/A | $4.71 |
| Revenue Next Year | N/A | $4.67 |
| P/E Ratio | ★ N/A | $25.95 |
| Revenue Growth | N/A | ★ 57.23 |
| 52 Week Low | $11.83 | $69.70 |
| 52 Week High | $31.44 | $89.73 |
| Indicator | GHRS | STRA |
|---|---|---|
| Relative Strength Index (RSI) | 47.40 | 50.43 |
| Support Level | $26.32 | $77.33 |
| Resistance Level | $28.96 | $84.83 |
| Average True Range (ATR) | 1.06 | 2.25 |
| MACD | -0.26 | -0.23 |
| Stochastic Oscillator | 31.62 | 36.16 |
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.